Human Menopausal Gonadotropin
HMG 150 IU delivers a precisely dosed, research-grade preparation of Human Menopausal Gonadotropin, a naturally occurring hormone complex extracted from the urine of postmenopausal women. This biologically active preparation contains both Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) in a balanced 1:1 ratio—typically 75 IU of each per 150 IU vial. These gonadotropins are fundamental regulators of reproductive function in both males and females. In males, LH stimulates Leydig cells in the testes to produce testosterone, while FSH supports Sertoli cell function and spermatogenesis (sperm production). This dual-action makes HMG uniquely valuable for research into complete hypothalamic-pituitary-gonadal (HPG) axis stimulation and fertility restoration.
For bodybuilders, athletes, and fertility researchers in the USA, Dragon Pharma HMG 150 IU offers a comprehensive research tool for studying both testosterone production and spermatogenic recovery. Unlike Human Chorionic Gonadotropin (HCG), which mimics only LH activity, HMG provides the complete natural gonadotropin profile. This makes it particularly valuable for research on post-cycle recovery where both testosterone normalization and fertility restoration are study endpoints. The 150 IU concentration is ideal for research protocols requiring precise titration and controlled stimulation of the HPG axis. Beyond fertility studies, HMG is researched for its potential in treating hypogonadism, investigating testicular function, and understanding the complex interplay between FSH and LH in male reproductive health. Manufactured by Dragon Pharma under strict quality control in certified European facilities, each vial ensures consistent bioactivity and purity for reliable endocrine research outcomes.
Key Benefits:
Each 2 mL vial contains 150 IU of highly purified Human Menopausal Gonadotropin (typically 75 IU FSH + 75 IU LH) as a sterile lyophilized powder, processed and standardized under Dragon Pharma's exacting pharmaceutical-grade quality standards.
| Product Name | HMG 150 IU |
| Manufacturer | Dragon Pharma |
| Substance | Human Menopausal Gonadotropin (HMG) |
| Packaging | 2 mL glass vial, lyophilized powder |
| Lab Test Result | Biologically standardized to 150 IU (75 IU FSH + 75 IU LH) |
| Half-Life | FSH: ~24 hours; LH: ~1-2 hours (combined effect persists 24-48 hours) |
| Recommended Cycle | Research protocols vary: 2-4 weeks for PCT studies, 4-12 weeks for fertility/hypogonadism research. |
| Form | Lyophilized (freeze-dried) powder for reconstitution |
| Aromatization | Indirect potential via increased testosterone production |
| Dosage (Research Models) | Typically studied with every-other-day or 3x weekly subcutaneous/intramuscular administration. |
Research Application Only: This information summarizes scientific literature for educational context. Dragon Pharma HMG 150 IU is a research chemical for laboratory investigation, not for human consumption.
In experimental settings, HMG is reconstituted with bacteriostatic water. Research typically utilizes subcutaneous or intramuscular administration. Due to the combined half-lives of FSH (~24h) and LH (~1-2h), study protocols often employ every-other-day or three-times-weekly dosing rather than daily administration. Research on post-cycle recovery usually incorporates HMG in the later stages of a cycle or during the transition to PCT. For fertility studies, longer protocols (8-12 weeks) are common to allow for complete spermatogenic cycle support. Studies monitoring testosterone, estradiol, and sperm parameters (count, motility, morphology) are standard in HMG research. Aromatase inhibitors like Aromasin may be included in study designs to manage potential estrogen conversion from increased testosterone.
HMG is often researched AS PART of PCT protocols rather than requiring its own PCT. When used in post-cycle recovery studies, it's typically combined with SERMs like Clomid or Nolvadex for comprehensive HPTA restart. After HMG administration ceases, natural production should resume if the HPTA has been properly stimulated. Some research protocols incorporate a taper rather than abrupt cessation. For ongoing testicular support after HMG research, natural supplements or lower-dose HCG might be studied.
HMG is frequently studied alongside other compounds for enhanced effects. For comprehensive PCT research, it combines with SERMs like Toremfine. With aromatase inhibitors like Arimidex, it allows study of testosterone elevation without excessive estrogen conversion. For fertility studies, combining with antioxidants like L-Carnitine may enhance sperm parameters. In hypogonadism research, pairing with Enclomiphene could be explored for sustained natural production. For bodybuilding recovery, combining with GHRP-2 may study synergistic anabolic effects.
Proper storage is critical to maintain the biological activity of this protein hormone preparation.
HMG (Human Menopausal Gonadotropin) is a research preparation containing both Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). It's studied for:
Its dual-hormone composition makes it valuable for complete reproductive system research.
In male research models, HMG exerts two primary effects through its components:
This makes it valuable for studies on both testosterone restoration and fertility recovery. Unlike HCG (which only mimics LH), HMG provides the complete natural gonadotropin signal for comprehensive reproductive function research.
Yes, through its LH component. LH (Luteinizing Hormone) binds to receptors on Leydig cells in the testes, stimulating testosterone synthesis and secretion. In research, HMG administration typically increases testosterone levels within days to weeks, depending on the study protocol. However, HMG also contains FSH, which doesn't directly increase testosterone but supports testicular health and spermatogenesis. For research focused solely on testosterone elevation without fertility aspects, HCG (which mimics only LH) might be a more specific research tool.
For research purposes, they serve different objectives. HMG contains both FSH and LH, making it superior for studies on COMPLETE reproductive recovery (testosterone + fertility). HCG mimics only LH, so it's better for research focused solely on testosterone stimulation without the fertility component. HMG is more expensive and less stable in solution. HCG has a longer half-life. The choice depends on research goals: comprehensive fertility/testosterone studies (HMG) vs. testosterone-only research (HCG). Some studies use both sequentially for optimal results.
For optimal research outcomes: Unreconstituted powder should be refrigerated at 2°C-8°C (36°F-46°F)—DO NOT FREEZE. After reconstitution with bacteriostatic water, use immediately or refrigerate and use within 24-48 hours. The protein hormones degrade more rapidly in solution. Never freeze reconstituted HMG as freezing can denature the proteins. Always use sterile technique to prevent bacterial contamination that could compromise research results or cause protein degradation.